rhodamine b has been researched along with gemcitabine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ishikawa, N; Mizumoto, K; Murakami, M; Nagai, E; Ogura, Y; Ohuchida, K; Tanaka, M; Yamada, D | 1 |
Idage, BB; Idage, SB; Munot, NM; Surwase, SS | 1 |
2 other study(ies) available for rhodamine b and gemcitabine
Article | Year |
---|---|
Strategy for prevention of local recurrence of pancreatic cancer after pancreatectomy: antitumor effect of gemcitabine mixed with fibrin glue in an orthotopic nude mouse model.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Combined Modality Therapy; Deoxycytidine; Fibrin Tissue Adhesive; Fluorescent Dyes; Gemcitabine; Humans; Mice; Mice, Nude; Neoplasm Recurrence, Local; Neoplasm Transplantation; Pancreatectomy; Pancreatic Neoplasms; Rhodamines; Transplantation, Heterologous | 2006 |
Tailoring the properties of mPEG-PLLA nanoparticles for better encapsulation and tuned release of the hydrophilic anticancer drug.
Topics: Animals; Antineoplastic Agents; Delayed-Action Preparations; Deoxycytidine; Drug Delivery Systems; Drug Liberation; Fluorescent Dyes; Gemcitabine; Hep G2 Cells; Humans; Hydrophobic and Hydrophilic Interactions; Male; MCF-7 Cells; Microscopy, Electron, Scanning; Nanoparticles; Particle Size; Polyesters; Polyethylene Glycols; Rats, Wistar; Rhodamines | 2017 |